These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 34277749

  • 1. Acute Effects of Pimobendan on Cardiac Function in Dogs With Tachycardia Induced Dilated Cardiomyopathy: A Randomized, Placebo-Controlled, Crossover Study.
    Abbott-Johnson K, Pierce KV, Roof S, Del Rio CL, Hamlin R.
    Front Vet Sci; 2021; 8():646437. PubMed ID: 34277749
    [Abstract] [Full Text] [Related]

  • 2. Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study.
    Oldach MS, Ueda Y, Ontiveros ES, Fousse SL, Harris SP, Stern JA.
    Front Vet Sci; 2019; 6():15. PubMed ID: 30778391
    [Abstract] [Full Text] [Related]

  • 3. The effect of treatment with pimobendan in dogs with preclinical mitral valve disease - a placebo-controlled double-blinded crossover study.
    Klein S, Nolte I, Rumstedt K, Sehn M, Raue JF, Weiner F, Treese JS, Beyerbach M, Bach JP.
    BMC Vet Res; 2021 Sep 25; 17(1):310. PubMed ID: 34563187
    [Abstract] [Full Text] [Related]

  • 4. Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly - a randomised, double-blinded trial.
    Iwanuk N, Nolte I, Wall L, Sehn M, Raue J, Pilgram A, Rumstedt K, Bach JP.
    BMC Vet Res; 2019 Jul 09; 15(1):237. PubMed ID: 31288807
    [Abstract] [Full Text] [Related]

  • 5. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K.
    J Vet Intern Med; 2013 Jul 09; 27(6):1452-62. PubMed ID: 24128373
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs.
    Atkinson KJ, Fine DM, Thombs LA, Gorelick JJ, Durham HE.
    J Vet Intern Med; 2009 Jul 09; 23(6):1190-6. PubMed ID: 19780931
    [Abstract] [Full Text] [Related]

  • 7. Effect of standard-dose and high-dose pimobendan on select indices of renal and cardiac function in dogs with American College of Veterinary Internal Medicine stage B2 myxomatous mitral valve disease.
    Kaplan JL, Visser LC, Gunther-Harrington CT, Ontiveros ES, Wittenburg LA, Palm CA, Stern JA.
    J Vet Intern Med; 2022 Nov 09; 36(6):1892-1899. PubMed ID: 36098206
    [Abstract] [Full Text] [Related]

  • 8. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
    Boswood A, Häggström J, Gordon SG, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Watson P.
    J Vet Intern Med; 2016 Nov 09; 30(6):1765-1779. PubMed ID: 27678080
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy.
    Fuentes VL, Corcoran B, French A, Schober KE, Kleemann R, Justus C.
    J Vet Intern Med; 2002 Nov 09; 16(3):255-61. PubMed ID: 12041654
    [Abstract] [Full Text] [Related]

  • 10. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
    O'Grady MR, Minors SL, O'Sullivan ML, Horne R.
    J Vet Intern Med; 2008 Nov 09; 22(4):897-904. PubMed ID: 18537880
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.
    Boswood A, Gordon SG, Häggström J, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Schummer C, Watson P.
    J Vet Intern Med; 2018 Jan 09; 32(1):72-85. PubMed ID: 29214723
    [Abstract] [Full Text] [Related]

  • 12. Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease.
    Sarcinella F, Neves J, Maddox TW, Hodgkiss-Geere HM, Bode EF, Dukes-McEwan J.
    Open Vet J; 2020 Jan 09; 9(4):375-383. PubMed ID: 32042661
    [Abstract] [Full Text] [Related]

  • 13. Effects of pimobendan for mitral valve regurgitation in dogs.
    Kanno N, Kuse H, Kawasaki M, Hara A, Kano R, Sasaki Y.
    J Vet Med Sci; 2007 Apr 09; 69(4):373-7. PubMed ID: 17485924
    [Abstract] [Full Text] [Related]

  • 14. Effects of intravenous administration of pimobendan on hemodynamic indices and indices of left atrial longitudinal strain derived from speckle-tracking echocardiography in healthy dogs.
    Miki S, Nakamura K, Morita T, Osuga T, Kawamoto S, Sasaki N, Takiguchi M.
    Am J Vet Res; 2021 Oct 09; 82(10):795-801. PubMed ID: 34554874
    [Abstract] [Full Text] [Related]

  • 15. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: data from the Acorn trial.
    Park SM, Park SW, Casaclang-Verzosa G, Ommen SR, Pellikka PA, Miller FA, Sarano ME, Kubo SH, Oh JK.
    Am Heart J; 2009 Apr 09; 157(4):762.e3-10. PubMed ID: 19332207
    [Abstract] [Full Text] [Related]

  • 16. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
    Lake-Bakaar GA, Singh MK, Kass PH, Griffiths LG.
    J Vet Cardiol; 2015 Jun 09; 17(2):120-8. PubMed ID: 26007710
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic effect of pimobendan following intramuscular and intravenous administration in healthy dogs: A pilot study.
    Enokizono M, Mandour AS, Komeda S, Goya S, Takeuchi A, Katoh K, Yairo A, Yilmaz Z, Shimada K, Tanaka R.
    Front Vet Sci; 2022 Jun 09; 9():969304. PubMed ID: 36311676
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study).
    Summerfield NJ, Boswood A, O'Grady MR, Gordon SG, Dukes-McEwan J, Oyama MA, Smith S, Patteson M, French AT, Culshaw GJ, Braz-Ruivo L, Estrada A, O'Sullivan ML, Loureiro J, Willis R, Watson P.
    J Vet Intern Med; 2012 Jun 09; 26(6):1337-49. PubMed ID: 23078651
    [Abstract] [Full Text] [Related]

  • 19. Pimobendan prevents cardiac dysfunction, mitigates cardiac mitochondrial dysfunction, and preserves myocyte ultrastructure in a rat model of mitral regurgitation.
    Boonpala P, Saengklub N, Srikam S, Ji-Au W, Panyasing Y, Kumphune S, Kijtawornrat A.
    BMC Vet Res; 2023 Aug 23; 19(1):130. PubMed ID: 37612694
    [Abstract] [Full Text] [Related]

  • 20. Effect of pimobendan on left atrial function: an echocardiographic pilot study in 11 healthy cats.
    Baron Toaldo M, Pollesel M, Diana A.
    J Vet Cardiol; 2020 Apr 23; 28():37-47. PubMed ID: 32244178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.